ORONTO, Ontario, Sept. 29, 2017 /Weed Wire/ — Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports the appointment of Mr. Matthew Murphy, the former U.S. Drug Enforcement Administration (“DEA”) Chief of Pharmaceutical Investigations, to the Advisory Board of the Company.
Tag Archives: Pharmaceutical
OTTAWA, Ontario, July 5, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF), today announced that it has strengthened its position on bringing marijuana to patients in the form of a prescription drug.
ALBUQUERQUE, N.M., June 28, 2017 /Weed Wire/ —Ultra Health, New Mexico’s #1 medical cannabis company with a nationwide presence, has released the first pharmaceutical grade, accurately dosed medical cannabis products to the New Mexico market.
Medical Marijuana, Inc. holds the distinction of being the first publicly listed marijuana stock, and its diversity is rare, but is it worth investing in?
At the California Cannabis Business Expo on March 8, 2017, entrepreneurs and investors interested in the science and technology of medical cannabis were given a crash course in the future of cannabis, and cannabidiol, as an alternative to pharmaceuticals by Hemp Business Journal founder Sean Murphy.
PETACH TIKVA, Israel, October 20, 2016 /Weed Wire/ — OWC Pharmaceutical Research Corp. (OTCQB: OWCP), (“OWC” or the “Company”) today announced that it has completed the development of a proprietary, cannabinoid-enriched sublingual tablet (the “Tablet”) for the administration of medical cannabis.
NEW YORK, Oct. 20, 2016 /Weed Wire/ — Columbia Care LLC (“CC”), a leading national medical marijuana product development, manufacturing and distribution company, today announced the launch of its line of controlled-dose, solid-fill medical cannabinoid capsules.
GW Pharmaceuticals Plc (Nasdaq:GWPH), a developer of marijuana-based epilepsy treatments, is working with an investment bank after other drugmakers approached it to express interest in an acquisition, people familiar with the matter said.
The medical sector of the cannabis industry continues to explode behind constant research and innovative studies for identifying viable cancer treatments and other therapies for different ailments.
HARTFORD, Conn., May 2, 2016 /Weed Wire/ — On Friday, HB 5450 passed the State Senate after passing the House on April 20th. The Department of Consumer Protection commends the members of the legislature who supported this thoughtful expansion of Connecticut’s medical marijuana program.
GW Pharma is reportedly ramping up production of Epidiolex in anticipation of FDA approval and the significant commercial demand for the drug that would follow.
LAS VEGAS, Nev., Nov. 4, 2015 /Weed Wire/ — Sage Analytics, the developers of a new generation of portable, laboratory-quality cannabis potency measurement systems, announced that it will unveil significant new features and improvements to the Beacon™ at the Marijuana Business Conference and Expo in Las Vegas.
There are several different schools of thought within the industry and investment community on which companies make better if not lower risk investments, as well as which companies in the still-developing market are likely to go public first.
It has been a bit of a dry spell for decent IPOs in the cannabis space. But the rains have come down with the initial public offering of Devon, Pennsylvania-based Zynerba Pharmaceuticals (NASDAQ: ZYNE).
Last Wednesday, two pain specialists that were top subscribers of Insys Therapeutics’ (NASDAQ: INSY) leading prescription therapy Subsys were arrested, as part of a year-long operation by the DEA.
Last week, the Florida Department of Health announced it plans to use its earmarked CBD research funds to test Epidiolex, a drug patented and produced by the publicly traded pharmaceutical company, GW Pharma (NASDAQ: GWPH).
Massachusetts Cannabis Research Labs is the only ISO-17025 accredited medical marijuana testing laboratory located on the East Coast. MCR Labs offers quality assurance in testing all MMJ products, marijuana buds as well as MIP’s. The laboratory utilizes methodologies from the pharmaceutical industry to further improve marijuana test accuracy and lower costs.